Clinials

Medrio is on a mission to ease complexity in today’s hybrid, decentralized, and site-based clinical trials by delivering a flexible suite of eClinical technologies and services, including EDC, eCOA, ePRO, eConsent, Direct Data Capture, and Randomization and Trial Supply Management (RTSM). Trusted by CROs, sponsors, and sites across all therapeutic areas and trial phases from study startup and feasibility to post-market approval, we are industry-recognized for delivering eClinical software with intuitive interfaces and time-saving “drag and drop” configurations as well as high-touch customer engagement, onboarding, and support services. Medrio’s innovative software, as well as the robust and flexible training and support resources we provide our customers, have earned us a 98% customer satisfaction rating.

Advancing AI to eliminate trial and error in medicine. Our digital twins enable confident and quick clinical trials. We work in neuroscience, immunology, metabolic disease, and more. TwinRCTs reach full enrollment sooner because they require fewer patients to achieve the same power as traditional trial designs. Shorten time to enrollment in late-stage studies. TwinRCTs improve the ability to observe treatment effects in early-stage studies by increasing power without adding more patients. Make confident decisions from early-stage studies and attract study participants. TwinRCTs give participants a greater chance of receiving the experimental treatment because they use smaller control groups. Position clinical trials with digital twins for regulatory success. Unlearn is engineering the future of medicine with artificial intelligence. We invent and deploy new types of generative models trained on extensive patient-level data from previous studies.